Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Primary Care Physicians' Action Plans for Responding to Results of Screening Tests Based on the Concept of Quaternary Prevention

  • Bae, Jong-Myon (Department of Preventive Medicine, Jeju National University School of Medicine) ;
  • Jamoulle, Marc (Department of General Practice, University of Liege)
  • Received : 2016.06.11
  • Accepted : 2016.10.13
  • Published : 2016.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Since noncommunicable diseases (NCDs) are generally controllable rather than curable, more emphasis is placed on prevention than on treatment. For the early detection of diseases, primary care physicians (PCPs), as well as general practitioners and family physicians, should interpret screening results accurately and provide screenees with appropriate information about prevention and treatment, including potential harms. The concept of quaternary prevention (QP), which was introduced by Jamoulle and Roland in 1995, has been applied to screening results. This article summarizes situations that PCPs encounter during screening tests according to the concept of QP, and suggests measures to face such situations. It is suggested that screening tests be customized to fit individual characteristics instead of being performed based on general guidelines. Since screening tests should not be carried out in some circumstances, further studies based on the concept of prevention levels proposed by Jamoulle and Roland are required for the development of strategies to prevent NCDs, including cancers. Thus, applying the concept of QP helps PCPs gain better insights into screening tests aimed at preventing NCDs and also helps improve the doctor-patient relationship by helping screenees understand medical uncertainties.

Keywords

References

  1. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. 1971. Milbank Q 2005;83 (4):731-757. https://doi.org/10.1111/j.1468-0009.2005.00398.x
  2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3(11):e442. https://doi.org/10.1371/journal.pmed.0030442
  3. Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med 2013;369(14):1336-1343. https://doi.org/10.1056/NEJMra1109345
  4. Dean E. Physical therapy in the 21st century (Part I): toward practice informed by epidemiology and the crisis of lifestyle conditions. Physiother Theory Pract 2009;25(5-6):330-353. https://doi.org/10.1080/09593980802668027
  5. Health Quality Ontario. Continuity of care to optimize chronic disease management in the community setting: an evidence-based analysis. Ont Health Technol Assess Ser 2013;13(6):1-41.
  6. Hakkarainen KM, Gyllensten H, JOnsson AK, Andersson Sundell K, Petzold M, Hagg S. Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults. Br J Clin Pharmacol 2014; 78(1):170-183. https://doi.org/10.1111/bcp.12314
  7. Harris M. The role of primary health care in preventing the onset of chronic disease, with a particular focus on the lifestyle risk factors of obesity, tobacco and alcohol; 2008 [cited 2016 Oct 20]. Available from: http://www.preventativehealth.org.au/internet/preventativehealth/publishing.nsf/Content/0FBE203C1C547A82CA257529000231BF/$File/commpaper-primary-hlth-care-harris.pdf.
  8. Dans LF, Silvestre MA, Dans AL. Trade-off between benefit and harm is crucial in health screening recommendations. Part I: general principles. J Clin Epidemiol 2011;64(3):231-239. https://doi.org/10.1016/j.jclinepi.2010.09.009
  9. Wald NJ. Guidance on terminology. J Med Screen 2006;13(1):53. https://doi.org/10.1258/096914106776179818
  10. Saquib N, Saquib J, Ioannidis JP. Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials. Int J Epidemiol 2015;44(1): 264-277. https://doi.org/10.1093/ije/dyu140
  11. Gigerenzer G. Full disclosure about cancer screening. BMJ 2016;352:h6967.
  12. Khunger M, Kumar U, Roy HK, Tiwari AK. Dysplasia and cancer screening in 21st century. APMIS 2014;122(8):674-682. https://doi.org/10.1111/apm.12283
  13. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA 2014; 311(13):1327-1335. https://doi.org/10.1001/jama.2014.1398
  14. Walter LC, Schonberg MA. Screening mammography in older women: a review. JAMA 2014;311(13):1336-1347. https://doi.org/10.1001/jama.2014.2834
  15. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007;146(7):516-526. https://doi.org/10.7326/0003-4819-146-7-200704030-00008
  16. McCartney M. Margaret McCartney: cancer strategy should be led by evidence. BMJ 2015;350:h735. https://doi.org/10.1136/bmj.h735
  17. Gates TJ. Screening for cancer: evaluating the evidence. Am Fam Physician 2001;63(3):513-522.
  18. Barrett B, McKenna P. Communicating benefits and risks of screening for prostate, colon, and breast cancer. Fam Med 2011;43(4):248-253.
  19. Onega T, Beaber EF, Sprague BL, Barlow WE, Haas JS, Tosteson AN, et al. Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level. Cancer 2014;120(19):2955-2964. https://doi.org/10.1002/cncr.28771
  20. Chubak J, Boudreau DM, Fishman PA, Elmore JG. Cost of breast-related care in the year following false positive screening mammograms. Med Care 2010;48(9):815-820. https://doi.org/10.1097/MLR.0b013e3181e57918
  21. Anhang Price R, Zapka J, Edwards H, Taplin SH. Organizational factors and the cancer screening process. J Natl Cancer Inst Monogr 2010;2010(40):38-57. https://doi.org/10.1093/jncimonographs/lgq008
  22. Young GP. Population-based screening for colorectal cancer: Australian research and implementation. J Gastroenterol Hepatol 2009;24 Suppl 3:S33-S42. https://doi.org/10.1111/j.1440-1746.2009.06069.x
  23. Leavell HR, Clark EG. Preventive medicine for the doctor in his community: an epidemiologic approach. 3rd ed. New York: McGraw-Hill; 1960, p. 20-21.
  24. Clark EG. Natural history of syphilis and levels of prevention. Br J Vener Dis 1954;30(4):191-197.
  25. Mahon SM. Principles of cancer prevention and early detection. Clin J Oncol Nurs 2000;4(4):169-176.
  26. Bae JM. The author reply: a comment on "quaternary prevention in public health". J Prev Med Public Health 2016;49(2):141. https://doi.org/10.3961/jpmph.16.032
  27. Jamoulle M, Roland M. Quaternary prevention; 1995 [cited 2016 Feb 24]. Available from: http://www.ph3c.org/PH3C/docs/27/000103/0000261.pdf.
  28. Jamoulle M. First do not harm. J Midlife Health 2015;6(2):51-52.
  29. Widmer D, Herzig L, Jamoulle M. Quaternary prevention: is acting always justified in family medicine? Rev Med Suisse 2014;10(430):1052-1056 (French).
  30. Sadegh-Zadeh K. Handbook of analytic philosophy of medicine. 2nd ed. Dordrecht: Springer; 2015, p. 37-46.
  31. Usherwood TP. Responses to illness--implications for the clinician. J R Soc Med 1990;83(4):205-207. https://doi.org/10.1177/014107689008300402
  32. Green AR, Carrillo JE, Betancourt JR. Why the disease-based model of medicine fails our patients. West J Med 2002;176(2): 141-143.
  33. Wakefield JC. The concept of mental disorder: diagnostic implications of the harmful dysfunction analysis. World Psychiatry 2007;6(3):149-156.
  34. van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998;51(5):367-375. https://doi.org/10.1016/S0895-4356(97)00306-5
  35. Sinnott C, Mc Hugh S, Browne J, Bradley C. GPs' perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open 2013;3(9):e003610. https://doi.org/10.1136/bmjopen-2013-003610
  36. Kiviniemi MT, Hay JL, James AS, Lipkus IM, Meissner HI, Stefanek M, et al. Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group. Cancer Epidemiol Biomarkers Prev 2009;18(11):3133-3137. https://doi.org/10.1158/1055-9965.EPI-18-11-ASPO
  37. Boone E, Lewis L, Karp M. Discontent and confusion: primary care providers' opinions and understanding of current cervical cancer screening recommendations. J Womens Health (Larchmt) 2016;25(3):255-262. https://doi.org/10.1089/jwh.2015.5326
  38. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2009;59(1):27-41. https://doi.org/10.3322/caac.20008
  39. Maxim LD, Niebo R, Utell MJ. Screening tests: a review with examples. Inhal Toxicol 2014;26(13):811-828. https://doi.org/10.3109/08958378.2014.955932
  40. Plsek PE, Greenhalgh T. Complexity science: the challenge of complexity in health care. BMJ 2001;323(7313):625-628. https://doi.org/10.1136/bmj.323.7313.625
  41. Kramer BS, Croswell JM. Cancer screening: the clash of science and intuition. Annu Rev Med 2009;60:125-137. https://doi.org/10.1146/annurev.med.60.101107.134802
  42. Müller-Engelmann M, Keller H, Donner-Banzhoff N, Krones T. Shared decision making in medicine: the influence of situational treatment factors. Patient Educ Couns 2011;82(2):240-246. https://doi.org/10.1016/j.pec.2010.04.028
  43. Zapka J, Taplin SH, Price RA, Cranos C, Yabroff R. Factors in quality care--the case of follow-up to abnormal cancer screening tests--problems in the steps and interfaces of care. J Natl Cancer Inst Monogr 2010;2010(40):58-71. https://doi.org/10.1093/jncimonographs/lgq009
  44. Torke AM, Schwartz PH, Holtz LR, Montz K, Sachs GA. Older adults and forgoing cancer screening: "I think it would be strange". JAMA Intern Med 2013;173(7):526-531. https://doi.org/10.1001/jamainternmed.2013.2903
  45. Gomes LF, Gusso G, Jamoulle M. Teaching and learning quaternary prevention. Rev Bras Med Fam Comunidade 2015;10 (35):1-14.
  46. Levesque JF, Breton M, Senn N, Levesque P, Bergeron P, Roy DA. The interaction of public health and primary care: functional roles and organizational models that bridge individual and population perspectives. Public Health Rev 2013;35(1):1-27.
  47. Bae JM. Development and application of patient decision aids. Epidemiol Health 2015;37:e2015018. https://doi.org/10.4178/epih/e2015018
  48. Sieber WJ, Kaplan RM. Informed adherence: the need for shared medical decision making. Control Clin Trials 2000;21(5 Suppl):233S-240S. https://doi.org/10.1016/S0197-2456(00)00084-2
  49. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med 2014;371(19): 1765-1767. https://doi.org/10.1056/NEJMp1409841

Cited by

  1. Shared decision making: relevant concepts and facilitating strategies vol.39, pp.None, 2017, https://doi.org/10.4178/epih.e2017048
  2. National health examination expansion policy vol.60, pp.2, 2016, https://doi.org/10.5124/jkma.2017.60.2.104
  3. Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention vol.13, pp.40, 2016, https://doi.org/10.5712/rbmfc13(40)1860